VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LITS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LITSLite Strategy, Inc.
$0.88$6M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

LITS logoLite Strategy, Inc.(LITS)Earnings, Financials & Key Ratios

LITS•NASDAQ
$0.88
Price updated Jun 27, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryOncology Therapeutics Developers
AboutLite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.Show more
  • Revenue$0-100.0%
  • EBITDA-$17M-214.5%
  • Net Income-$16M-189.7%
  • EPS (Diluted)-2.39-189.5%
  • ROE-63.84%-203.5%

LITS Price & Volume

Lite Strategy, Inc. (LITS) stock price & volume — 10-year historical chart

Loading chart...

Persistent Operational Pivot Masks Existential Liquidity Risk

Investment Thesis • Updated 2026Q3

VerdictNeutral
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Existential capital depletion risk

Key Thesis Takeaways

  • Lite Strategy, Inc.
  • is currently undergoing a high-risk transition from legacy pharmaceutical operations to the cryptocurrency asset management sector, characterized by a complete cessation of revenue and significant ongoing overhead.
  • The firm's financial position is increasingly precarious, as evidenced by a $462.3 million accumulated deficit and a rapid decline in total assets from $113.3 million in 2026Q1 to $57.8 million in 2026Q3.
  • Investors should exercise extreme caution, as the company's current capital allocation strategy—including $1.8 million in share repurchases despite zero revenue—appears disconnected from the urgent need to fund a viable new business model.

Verdict Logic

Negative: The company exhibits an unsustainable cash burn profile with a $1.5 million negative free cash flow in 2026Q3 and no clear path to revenue generation following its total operational pivot.

LITS Growth Metrics

Lite Strategy, Inc. (LITS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-
TTM-

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-59.58%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-59.62%

Return on Capital

10 Years-33.09%
5 Years-33.09%
3 Years-25.69%
Last Year-69.89%

LITS Recent Earnings

Lite Strategy, Inc. (LITS) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 5/11 qtrs (71%)
Q2 2026Latest
May 13, 2026
Metric
Actual
Est
EPS
$0.66+78.8%
$3.12
Rev
—
$5M
Q1 2026
Feb 17, 2026
Metric
Actual
Est
EPS
$0.82
—
Rev
—
—
Q4 2025
Nov 14, 2025
Metric
Actual
Est
EPS
$0.12
—
Rev
—
—
Q4 2025
Sep 29, 2025
Metric
Actual
Est
EPS
$0.40
—
Rev
—
—
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 13, 2026
$0.66vs $3.12+78.8%
—vs $5M
Q1 2026Feb 17, 2026
$0.82
—
Q4 2025Nov 14, 2025
$0.12
—
Q4 2025Sep 29, 2025
$0.40
—
Based on last 11 quarters of dataView full earnings history →

Latest LITS News

Recent stock market news and headlines for Lite Strategy, Inc. (LITS)

GlobeNewsWire·Jun 19, 2026
Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam

SAN DIEGO, June 19, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (Nasdaq: LITS) ("Lite Strategy" or the "Company"), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today announced its participation in a featured panel at the Litecoin Foundation Summit, taking place June 22-23, 2026 at the Tobacco Theatre in Amsterdam, Netherlands. The Litecoin Foundation Summit is the flagship annual gathering of the Litecoin ecosystem, held this year in collaboration with Dutch Blockchain Week.

GlobeNewsWire·Jun 18, 2026
Lite Strategy Leads Strategic Investment in LitVM

SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (Nasdaq: LITS) (“Lite Strategy” or the “Company”), the first U.S. public company to adopt Litecoin (LTC) as its primary treasury reserve asset, today announced the closing of a $1.0 million lead strategic investment in ZK Innovations Inc., the developer of LitVM, the first zero-knowledge (ZK) Layer 2 platform built on Litecoin. The investment reflects Lite Strategy's belief that increasing Litecoin's utility and functionality can strengthen the network and increase long-term shareholder value.

Peers Comparison

Key metrics vs top competitors for Lite Strategy, Inc. (LITS)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
LITS logoLITSLite Strategy, Inc.Current
$0.88$5.86M-0.37-100%—-63.84%—
HCKT logoHCKTThe Hackett Group, Inc.
$11.29$284.74M24.02-2.62%4.75%15.84%—
ICFI logoICFIICF International, Inc.
$71.51$1.29B14.45-7.27%4.68%8.35%—
CASS logoCASSCass Information Systems, Inc.
$51.57$663.77M19.76-13.1%17.39%14.44%—
KFRC logoKFRCKforce Inc.
$49.51$904.94M25.26-5.43%2.6%27.22%—
FCN logoFCNFTI Consulting, Inc.
$151.10$4.55B18.342.44%6.88%15.14%—

Compare LITS vs Peers

Lite Strategy, Inc. (LITS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HCKT

Most directly comparable listed peer for LITS.

Scale Benchmark

vs MSFT

Larger-name benchmark to compare LITS against a more recognizable public peer.

Peer Set

Compare Top 5

vs HCKT, ICFI, CASS, KFRC

Get notified when LITS posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

LITS Frequently Asked Questions

Lite Strategy, Inc. (LITS) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
How fast is Lite Strategy, Inc. growing?

Lite Strategy, Inc. (LITS) saw revenue decline by 100.0% over the past year.

Is LITS profitable?

Lite Strategy, Inc. (LITS) reported a net loss of $60.8M for fiscal year 2025.

Dividend & Returns
What is LITS's return on equity?

Lite Strategy, Inc. (LITS) has a return on equity (ROE) of -63.8%. Negative ROE indicates the company is unprofitable.

What is Lite Strategy, Inc.'s free cash flow?

Lite Strategy, Inc. (LITS) had negative free cash flow of $10.4M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in LITS back in 2021?

Total return calculator · dividends reinvested · 5+ years of data

See returns →